Michael T. Jackson, formerly of Belvedere, California, has worked for decades building an accomplished career in emerging markets and hedge funds. He established SFG Asset Advisors in 2001, and subsequently relocated from Belvedere to Florida. Throughout his career, Michael T. Jackson has demonstrated a passion for philanthropic work by supporting such initiatives as the founding of Napa Medical Research Foundation (NMRF).
NMRF regularly supports research exploring new treatments for disorders of the skeletal system and brain. The organization is currently participating in a number of research projects, including a study of greater trochanteric pain syndrome, or GTPS.
A condition typically found in both the elderly and middle-aged population, GTPS causes pain in the greater trochanter, which sits on the upper leg, near the hip joint. Individuals with this condition generally feel more intense pain after engaging in rigorous activity or lying on the afflicted area.
Through the support of NMRF, researchers have been able to hypothesize that tearing of the rotator cuff elicited the most persistent symptoms in GTPS patients. Therefore, scientists are looking to develop a treatment that involves the use of plasma platelets. When injected into the trochanter, this solution should help patients experience rapid healing and overcome their symptoms permanently.
This research has already elicited promising results. Between 80 percent and 90 percent of patients who received this experimental treatment saw an eradication of all their GTPS symptoms after a month. In the future, NMRF and its affiliate researchers hope to enlist the help of more patients for further trials.
A seasoned investor, philanthropist, and business leader, Michael T. Jackson is a former resident of Belvedere, California. Now residing in Florida, Michael T. Jackson leverages approximately 30 years of hedge fund and investment experience to guide young professionals with SFG Asset Advisors. Further, the former Belvedere resident is the founder of Napa Medical Research Foundation (NMRF), which conducts research into orthopedic regenerative healing.
One of NMRF’s most recent studies examined cervical facet arthritis, which most commonly affects individuals over the age of 50. Treatments for the condition generally involve injections of corticosteroids and biologic agents, such as plasma and bone marrow. In many cases, injections utilize fluoroscopic (x-ray) guidance. A time-consuming technique, fluoroscopically guided injections may have an accuracy rate of below 80 percent.
The study examined a new ultrasound-guided technique capable of delivering biologic agents to affected areas with greater accuracy sans radiation. Phase I trials have demonstrated the technique to be between 95 and 100 percent accurate. The data from the trial is now in the hands of a statistician, and the study’s findings are being prepared for publication.